Search results
Pages
-
- General Practitioners and Breast Surgeons in France, Germany, Netherlands and the UK show variable breast cancer risk communication profiles
-
- Assessing treatment effects in older breast cancer patients: Systematic review of observational research methods
-
- Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
-
- The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
-
- Contralateral breast cancer risk in relation to tumor morphology and age-in which patients is preoperative MRI justified?
-
- Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies - A population-based study
-
- Survival and relapse free period of 2926 unselected older breast cancer patients: A FOCUS cohort study
-
- Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases
-
- Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
-
- The prognostic relevance of the mitotic activity index in axillary lymph node-negative breast cancer
-
- Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases
-
- Patients' preferences for surgical and adjuvant systemic treatment in early breast cancer: A systematic review
-
- Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
-
- Choosing relevant endpoints for older breast cancer patients in clinical trials: an overview of all current clinical trials on breast cancer treatment
-
- The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review